Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy (QCA) and Safety of the BioFreedom™ Biolimus A9™ CoCr Stent in a Randomised Trial in Patients With CAD

NCT03307213 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT03307213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03307213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy (QCA) and Safety of the BioFreedom™ Biolimus A9™ CoCr Stent in a Randomised Trial in Patients With CAD
Lead sponsor
Biosensors Europe SA
Phase
Not applicable
Overall status
Unknown status
Start date
June 19, 2018
Completion date
March 31, 2021
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac death, coronary artery disease, myocardial infarction